- Home
- FORM vs AXSM Comparison
FORM vs AXSM Comparison
Compare FORM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- AXSM
- Stock Information
- Founded
- FORM 1993
- AXSM 2012
- Country
- FORM United States
- AXSM United States
- Employees
- FORM N/A
- AXSM N/A
- Industry
- FORM Semiconductors
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- FORM Technology
- AXSM Health Care
- Exchange
- FORM Nasdaq
- AXSM Nasdaq
- Market Cap
- FORM 3.0B
- AXSM 4.2B
- IPO Year
- FORM N/A
- AXSM 2015
- Fundamental
- Price
- FORM $43.14
- AXSM $84.60
- Analyst Decision
- FORM Strong Buy
- AXSM Strong Buy
- Analyst Count
- FORM 8
- AXSM 14
- Target Price
- FORM $56.00
- AXSM $125.54
- AVG Volume (30 Days)
- FORM 1.1M
- AXSM 893.5K
- Earning Date
- FORM 02-05-2025
- AXSM 02-18-2025
- Dividend Yield
- FORM N/A
- AXSM N/A
- EPS Growth
- FORM N/A
- AXSM N/A
- EPS
- FORM 1.72
- AXSM N/A
- Revenue
- FORM $742,279,000.00
- AXSM $338,457,000.00
- Revenue This Year
- FORM $17.59
- AXSM $44.77
- Revenue Next Year
- FORM $8.82
- AXSM $67.70
- P/E Ratio
- FORM $25.04
- AXSM N/A
- Revenue Growth
- FORM 12.31
- AXSM 51.47
- 52 Week Low
- FORM $37.25
- AXSM $64.11
- 52 Week High
- FORM $63.63
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- FORM 47.00
- AXSM 43.66
- Support Level
- FORM $41.21
- AXSM $79.19
- Resistance Level
- FORM $48.69
- AXSM $87.53
- Average True Range (ATR)
- FORM 2.14
- AXSM 4.37
- MACD
- FORM -0.35
- AXSM -0.02
- Stochastic Oscillator
- FORM 25.80
- AXSM 61.27
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.